- Home
- INN vs MREO Comparison
INN vs MREO Comparison
Compare INN & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INN
- MREO
- Stock Information
- Founded
- INN 2010
- MREO 2015
- Country
- INN United States
- MREO United Kingdom
- Employees
- INN N/A
- MREO N/A
- Industry
- INN Real Estate Investment Trusts
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- INN Real Estate
- MREO Health Care
- Exchange
- INN Nasdaq
- MREO Nasdaq
- Market Cap
- INN 692.3M
- MREO 577.6M
- IPO Year
- INN 2011
- MREO N/A
- Fundamental
- Price
- INN $6.23
- MREO $3.68
- Analyst Decision
- INN Hold
- MREO Strong Buy
- Analyst Count
- INN 1
- MREO 4
- Target Price
- INN N/A
- MREO $7.50
- AVG Volume (30 Days)
- INN 592.6K
- MREO 769.7K
- Earning Date
- INN 11-04-2024
- MREO 11-12-2024
- Dividend Yield
- INN 5.17%
- MREO N/A
- EPS Growth
- INN N/A
- MREO N/A
- EPS
- INN 0.07
- MREO N/A
- Revenue
- INN $736,287,000.00
- MREO $1,000,000.00
- Revenue This Year
- INN $0.45
- MREO $16.39
- Revenue Next Year
- INN $1.46
- MREO $9.44
- P/E Ratio
- INN $85.60
- MREO N/A
- Revenue Growth
- INN 0.72
- MREO N/A
- 52 Week Low
- INN $5.66
- MREO $1.86
- 52 Week High
- INN $7.22
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- INN 45.48
- MREO 39.84
- Support Level
- INN $5.98
- MREO $3.18
- Resistance Level
- INN $6.60
- MREO $4.40
- Average True Range (ATR)
- INN 0.17
- MREO 0.24
- MACD
- INN -0.01
- MREO -0.06
- Stochastic Oscillator
- INN 40.85
- MREO 41.39
About INN Summit Hotel Properties Inc.
Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).